Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Roche’s vision-loss drug Vabysmo gets EU nod By: MarketWatch September 19, 2022 at 02:01 AM EDT The approval from the European Commission--the EU's executive arm--comes after four phase-3 studies showing vision gains and anatomical improvements in patients given the drug, Roche said. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Roche’s vision-loss drug Vabysmo gets EU nod By: MarketWatch September 19, 2022 at 02:01 AM EDT The approval from the European Commission--the EU's executive arm--comes after four phase-3 studies showing vision gains and anatomical improvements in patients given the drug, Roche said. Read More >>